12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in health care stocks on Tuesday. Notable gainers include Biodexa Pharmaceuticals (BDRX), Genelux (GNLX), Novo Integrated Sciences (NVOS), Bionomics (BNOX), Xylo Technologies (XYLO), and Accelerate Diagnostics (AXDX). On the losing side, Dare Bioscience (DARE), American Oncology Network (AONC), Akanda (AKAN), Scorpius Holdings (SCPX), Sonoma Pharmaceuticals (SNOA), and GT Biopharma (GTBP) experienced notable declines.
May 21, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Accelerate Diagnostics (AXDX) shares increased by 16.25% to $1.02, boosting its market value.
The significant price rise indicates positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
Biodexa Pharmaceuticals (BDRX) stock surged by 84.3% to $2.34, significantly increasing its market value.
The significant price increase suggests strong investor interest or positive news, likely leading to short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Bionomics (BNOX) shares rose 23.93% to $1.14, boosting its market cap to $12.1 million.
The significant price rise indicates positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Genelux (GNLX) shares increased by 28.6% to $5.53, boosting its market cap to $149.2 million.
The substantial price rise indicates positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Novo Integrated Sciences (NVOS) shares moved upwards by 24.55% to $0.54, increasing its market value.
The notable price increase suggests positive investor sentiment, likely leading to short-term upward movement.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Xylo Technologies (XYLO) shares rose 21.98% to $2.33, increasing its market value.
The notable price increase suggests positive investor sentiment, likely leading to short-term upward movement.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Akanda (AKAN) shares fell 25.44% to $0.1, significantly decreasing its market value.
The significant price drop suggests negative investor sentiment or adverse news, likely leading to short-term downward momentum.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
American Oncology Network (AONC) shares declined by 27.76% to $1.9 following the Q1 earnings report.
The significant price drop following the Q1 earnings report suggests negative investor sentiment, likely leading to short-term downward movement.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Dare Bioscience (DARE) stock fell 32.8% to $0.41, significantly decreasing its market value.
The significant price drop suggests negative investor sentiment or adverse news, likely leading to short-term downward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
GT Biopharma (GTBP) shares fell 20.4% to $6.21 following the Q1 earnings report.
The significant price drop following the Q1 earnings report suggests negative investor sentiment, likely leading to short-term downward movement.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Scorpius Holdings (SCPX) stock fell 25.13% to $0.12, significantly decreasing its market value.
The significant price drop suggests negative investor sentiment or adverse news, likely leading to short-term downward momentum.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Sonoma Pharmaceuticals (SNOA) shares decreased by 20.67% to $0.18, significantly decreasing its market value.
The significant price drop suggests negative investor sentiment or adverse news, likely leading to short-term downward momentum.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 100